IBSA Institut Biochimique is a multinational pharmaceutical, headquartered in Lugano, Switzerland

The current management acquired the ownership in 1985 and greatly expanded its assets: today the company develops and produces for a wide range of therapeutic areas and owns 65 exclusive registered patents, while several other products and patents are under enlargement.